Pantoprazole classification
Pro Research Analysisby 
Searched over 200M research papers for "pantoprazole classification"
Pantoprazole Classification and Clinical Relevance
Introduction to Pantoprazole: Proton Pump Inhibitor (PPI)
Pantoprazole is classified as a proton pump inhibitor (PPI), a class of drugs that reduce gastric acid secretion by inhibiting the H+/K+-ATPase enzyme in the stomach's parietal cells Garner1997Bardou2008Jungnickel2000. This mechanism of action makes PPIs highly effective in treating acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome Cheer2003Poole2001.
Pharmacokinetics and Pharmacodynamics of Pantoprazole
Pantoprazole is well absorbed when administered orally, with a bioavailability of approximately 77%, which remains consistent regardless of food intake Garner1997Jungnickel2000. It undergoes hepatic metabolism primarily via the cytochrome P450 system, specifically CYP2C19, and is converted to inactive metabolites . Unlike some other PPIs, pantoprazole does not significantly interact with other drugs metabolized by the cytochrome P450 system, making it a safer option for patients on multiple medications Garner1997Jungnickel2000.
Clinical Efficacy in Acid-Related Disorders
Gastroesophageal Reflux Disease (GERD)
Pantoprazole has been shown to be as effective as other PPIs, such as omeprazole and esomeprazole, in healing esophageal lesions and providing symptom relief in GERD patients Cheer2003Gillessen2004. Studies indicate that both 40 mg and 80 mg doses of pantoprazole are effective, with no significant difference in healing rates between the two dosages .
Peptic Ulcers and Helicobacter pylori Eradication
Pantoprazole is effective in treating peptic ulcers and is commonly used in combination with antibiotics for Helicobacter pylori eradication. It has shown similar efficacy to other PPIs in this regard, with eradication rates ranging from 71% to 93.8% . Additionally, pantoprazole is effective in preventing NSAID-induced peptic ulcers, providing a protective effect for patients requiring long-term NSAID therapy .
Zollinger-Ellison Syndrome
Pantoprazole is also effective in managing hypersecretory conditions such as Zollinger-Ellison syndrome. It helps maintain target acid output levels and is available in both oral and intravenous formulations, offering flexibility in administration Cheer2003Welage2000.
Safety and Tolerability
Pantoprazole is generally well tolerated, with common adverse effects including headache, diarrhea, and abdominal pain Jungnickel2000Poole2001. Its safety profile is comparable to other PPIs, and it has a low potential for drug interactions, making it a suitable option for long-term use in managing acid-related disorders Cheer2003Jungnickel2000.
Conclusion
Pantoprazole is a highly effective and well-tolerated proton pump inhibitor used in the treatment of various acid-related disorders. Its pharmacokinetic properties, minimal drug interactions, and availability in both oral and intravenous forms make it a versatile and valuable option in clinical practice.
Sources and full results
Most relevant research papers on this topic
Pantoprazole: a new and more specific proton pump inhibitor.
Pantoprazole is a new proton pump inhibitor with improved selectivity and pharmacokinetic properties, potentially achieving significant market penetration at the expense of lansoprazole and H2 blockers.
Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
Pantoprazole 40 mg once daily is well-tolerated and more effective than placebo in preventing peptic ulcers in patients with rheumatic diseases requiring continuous, long-term treatment with NSAIDs.
DOI
40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
Both 40 mg pantoprazole and 40 mg esomeprazole are equally effective for healing esophageal lesions and relieving gastroesophageal reflux disease-related symptoms in patients.
Pantoprazole.
Pantoprazole is a well-tolerated and effective proton-pump inhibitor for treating erosive esophagitis, duodenal and gastric ulcers, and acid production in Zollinger-Ellison syndrome.
DOI